导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.58% | 1853/4773 |
| 近一周 | -1.49% | 478/5462 |
| 近一月 | 0.59% | 538/5421 |
| 近一季 | -2.77% | 1299/5209 |
| 近半年 | -13.50% | 3852/4920 |
| 近一年 | 8.15% | 1218/4366 |
| 近两年 | 37.48% | 1997/2954 |
| 近三年 | 21.33% | 1422/2253 |
| 成立以来 | 83.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
8.52% 111/4961 |
-6.38% 3688/5312 |
- - |
- - |
| 2025 | 13.25% 2655/4813 |
-2.35% 2876/3635 |
0.99% 2506/4076 |
8.90% 3392/4524 |
5.45% 442/4813 |
| 2024 | 13.98% 1086/3463 |
6.91% 274/2808 |
0.62% 568/3014 |
9.24% 2709/3129 |
-3.00% 2227/3463 |
| 2023 | -1.98% 548/2656 |
12.05% 317/2280 |
0.43% 321/2385 |
-6.13% 1438/2515 |
-7.21% 2087/2655 |
| 2022 | -14.50% 373/2207 |
-8.39% 279/1919 |
4.26% 1028/2016 |
-12.12% 647/2113 |
1.87% 1108/2208 |
| 2021 | 14.21% 341/1822 |
4.68% 140/1255 |
4.65% 861/1330 |
5.42% 275/1466 |
-1.09% 1308/1822 |
| 2020 | - - |
- - |
-0.33% 1014/1067 |
16.32% 158/1164 |
10.99% 571/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证国企一带一路ETF联接A VS. 长安沪深300非周期A(740101) |